- Home
- LEGN vs BTG Comparison
LEGN vs BTG Comparison
Compare LEGN & BTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- BTG
- Stock Information
- Founded
- LEGN 2014
- BTG 2006
- Country
- LEGN United States
- BTG Canada
- Employees
- LEGN N/A
- BTG N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- BTG Precious Metals
- Sector
- LEGN Health Care
- BTG Basic Materials
- Exchange
- LEGN Nasdaq
- BTG Nasdaq
- Market Cap
- LEGN 5.4B
- BTG 4.9B
- IPO Year
- LEGN 2020
- BTG N/A
- Fundamental
- Price
- LEGN $38.96
- BTG $3.51
- Analyst Decision
- LEGN Strong Buy
- BTG Buy
- Analyst Count
- LEGN 12
- BTG 3
- Target Price
- LEGN $73.91
- BTG $4.12
- AVG Volume (30 Days)
- LEGN 1.6M
- BTG 47.2M
- Earning Date
- LEGN 08-08-2025
- BTG 08-07-2025
- Dividend Yield
- LEGN N/A
- BTG 3.43%
- EPS Growth
- LEGN N/A
- BTG N/A
- EPS
- LEGN N/A
- BTG N/A
- Revenue
- LEGN $728,303,000.00
- BTG $1,972,693,000.00
- Revenue This Year
- LEGN $65.49
- BTG $55.41
- Revenue Next Year
- LEGN $53.76
- BTG N/A
- P/E Ratio
- LEGN N/A
- BTG N/A
- Revenue Growth
- LEGN 112.46
- BTG 2.63
- 52 Week Low
- LEGN $27.34
- BTG $2.20
- 52 Week High
- LEGN $60.87
- BTG $3.83
- Technical
- Relative Strength Index (RSI)
- LEGN 66.26
- BTG 48.26
- Support Level
- LEGN $34.64
- BTG $3.40
- Resistance Level
- LEGN $39.88
- BTG $3.69
- Average True Range (ATR)
- LEGN 1.46
- BTG 0.12
- MACD
- LEGN 0.37
- BTG -0.03
- Stochastic Oscillator
- LEGN 87.67
- BTG 34.72
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About BTG B2Gold Corp Common shares (Canada)
B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.